Transgene
TNG | PA
Overview
Corporate Details
- ISIN(s):
- FR0005175080
- LEI:
- 969500PDJW8N0FSGGK69
- Country:
- France
- Address:
- 400 BOULEVARD GONTHIER D'ANDERNACH, 67400 ILLKIRCH-GRAFFENSTADEN
- Website:
- https://www.transgene.fr/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Transgene is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. A pioneer in viral vectors engineering, we have one ambition: design innovative treatments in the fight against cancer. Our approach uses the mechanisms of the immune response to enable the patient’s body to fight against disease.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-22 17:45 |
Regulatory News Service
Transgene présente des données de survie sans récidive à 24 mois sur l’ensemble…
|
French | 378.1 KB | |
| 2025-05-22 17:45 |
Regulatory News Service
Transgene to Present 24-month Disease-Free Survival Data from All Patients in P…
|
English | 412.3 KB | |
| 2025-05-15 17:45 |
Inside Information Statement
Assemblée Générale Mixte de Transgene du 15 mai 2025
|
French | 315.4 KB | |
| 2025-05-15 17:45 |
Inside Information Statement
Transgene's Combined General Meeting of May 15, 2025
|
English | 285.9 KB | |
| 2025-04-24 17:45 |
Quarterly Report
Transgene Provides Business and Financial Update for Q1 2025
|
English | 310.4 KB | |
| 2025-04-24 17:45 |
Earnings Release
Transgene fait le point sur ses activités et sa situation financière au premier…
|
French | 452.4 KB | |
| 2025-04-24 08:00 |
General Meeting Notice
Mise à disposition des documents préparatoires à l'Assemblée générale du 15 mai…
|
French | 277.8 KB | |
| 2025-04-24 08:00 |
General Meeting Notice
Availability of Preparatory Documents for the Combined General Meeting of May 1…
|
English | 262.6 KB | |
| 2025-04-23 17:45 |
Regulatory News Service
Transgene communiquera, dans une présentation orale rapide, de nouvelles donnée…
|
French | 414.8 KB | |
| 2025-04-23 17:45 |
Regulatory News Service
Transgene to Provide Updated Phase I Data in a Rapid Oral Presentation on Indiv…
|
English | 369.6 KB | |
| 2025-04-10 20:15 |
Registration Form
Mise à disposition du Document d’Enregistrement Universel (DEU) 2024 de Transge…
|
French | 140.9 KB | |
| 2025-04-10 20:15 |
Report Publication Announcement
Availability of Transgene’s 2024 Universal Registration Document (URD)
|
English | 171.0 KB | |
| 2025-04-10 15:38 |
Annual Report (ESEF)
Document d'enregistrement universel 2024
|
French | 5.3 MB | |
| 2025-04-01 17:45 |
Board/Management Change
Transgene recrute une Directrice des opérations techniques (CTO) pour accélérer…
|
French | 377.5 KB | |
| 2025-04-01 17:45 |
Board/Management Change
Transgene Appoints Chief Technical Officer (CTO) to Power Future Innovations
|
English | 390.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-30 | N/A | Other | Other | 30,898,876 | 32,999,999.57 EUR |
| 2023-05-26 | N/A | Other | Buy | 29,325 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
European Institute of Science AB | Sweden | EURI B | |
|
European Medical Solutions | Belgium | ALEMS | |
|
Evogene Ltd. | Israel | EVGN | |
|
Evolva Holding SA | Switzerland | EVE | |
|
EXACT Therapeutics AS | Norway | EXTX | |
|
Exosens | France | EXENS | |
|
ExpreS2ion Biotech Holding AB | Sweden | EXPRS2 | |
|
Fermentalg | France | ALGAE | |
|
Formycon AG | Germany | FYB | |
|
FRONTIER IP GROUP PLC | United Kingdom | FIPP |